Effect of a tailored home‐based exercise program in patients with systemic sclerosis: A randomized controlled trial

Objective The aim was to evaluate the effect of a home‐based exercise program on functional capacity, health‐related quality of life (HRQoL), and disability, in patients with systemic sclerosis (SSc). Methods A 6‐month randomized controlled trial was conducted on SSc patients by comparing a home‐bas...

Full description

Saved in:
Bibliographic Details
Published in:Scandinavian journal of medicine & science in sports 2020-09, Vol.30 (9), p.1675-1684
Main Authors: Filippetti, Mirko, Cazzoletti, Lucia, Zamboni, Francesco, Ferrari, Pietro, Caimmi, Cristian, Smania, Nicola, Tardivo, Stefano, Ferrari, Marcello
Format: Article
Language:English
Subjects:
Aged
Clinical trials
disability
Disability Evaluation
exercise therapy
Exercise Therapy - methods
Female
Home Care Services
Humans
Male
Middle Aged
Muscle Strength - physiology
muscles
Original
Quality of Life
resistance training
Scleroderma
Scleroderma, Systemic - rehabilitation
Surveys and Questionnaires
Systemic sclerosis
Walk Test
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective The aim was to evaluate the effect of a home‐based exercise program on functional capacity, health‐related quality of life (HRQoL), and disability, in patients with systemic sclerosis (SSc). Methods A 6‐month randomized controlled trial was conducted on SSc patients by comparing a home‐based minimally supervised exercise program (exercise on a stationary cycle and strengthening of upper limbs; stretching of the hands) with usual care. At baseline and after 3 and 6 months, the patients underwent: 6 minutes walking test; hand mobility in scleroderma test; maximal exercise test on an ergocycle; strength measures (handgrip, quadriceps, and biceps). HRQoL (short‐form 36 [SF‐36]) and disability (health assessment questionnaire disability index [HAQ‐DI]) were measured at the same time. Results Forty‐four patients participated in the study. Twenty‐two were randomly assigned to the intervention group (IG, mean age 63.60 ± 10.40 years) and 22 to the control group (CG, 61.80 ± 14.40 years). At 6 months, the distance walked in 6 minutes increased by 46 m (baseline 486, 95% CI 458‐513 m; 6 months 532, 95% CI 504‐561 m) in IG, whereas it decreased by 5 m (baseline 464, 95% CI 431‐497 m; 6 months 459, 95% CI 427‐490 m) in CG with a significantly different temporal trend at the between‐groups comparison (P 
ISSN:0905-7188
1600-0838
DOI:10.1111/sms.13702